Table 3.

Model estimates of societal costs avoided and QALYs gained. Costs in Euro 2018. 3% discount rate

Gender/Age group	Model estimates		CEA short*					CEA long*
			HIT†	LIT‡	Difference			HIT†	LIT‡	Difference
	Costs avoided	QALYs§ gained	NHp¶	NLp**	N††	Costs	QALYs§	NHs‡‡	NLs§§	N¶¶	Costs	QALYs§
Women
20–24	8142	0.61		1	−1	−8142	−0.61	na	na	na	na	na
25–29	8425	0.65	1		1	8425	0.65	na	na	na	na	na
35–39	9267	0.71	2	2	0			1	1	0
40–44	8532	0.71	5		5	42 658	3.55	4		4	34 126	2.84
45–49	6772	0.66	3	3	0			1	2	−1	−6772	−0.66
50–54	5228	0.61	4	3	1	5228	0.61	1	2	−1	−5228	−0.61
55–59	4542	0.43	4	2	2	9085	0.86	4	1	3	13 627	1.29
60–64	3336	0.32	4		4	13 342	1.29	2		2	6671	0.64
65–69	2023	0.33		1	−1	−2023	−0.33	na	na	na	na	na
Men
20–24	10 430	0.74	1		1	10 430	0.74	1		1	10 430	0.74
40–44	10 526	1.00	1		1	10 526	1.00	1		1	10 526	1.00
45–49	11 416	0.82	1	1	0			1	1	0
50–54	11 360	0.78		1	−1	−11 360	−0.78	na	na	na	na	na
65–69	4084	0.46	1		1	4084	0.46	1		1	4084	0.46
Total			27	14	13	82 253	7.44	17	7	10	67 466	5.71

*Cost-effectiveness analysis.

†High-intensity smoking cessation treatment, the HIT programme.

‡Low-intensity smoking cessation treatment, the LIT programme.

§Quality-adjusted life-years.

¶NHp—number of 6-month continuous abstinent participants HIT treatment programme according to 1-year follow-up.

**NLp—number of 6-month continuous abstinent participants LIT treatment programme according to 1-year follow-up.

††Difference in numbers of 6 -month continuous abstinent participants between the treatment programmes according to 1 -year follow-up.

‡‡NHs—number of sustained abstinent participants HIT treatment according to 5–8 years of follow-up.

§§NLs number of sustained abstinent participants LIT treatment according to 5–8 years of follow-up.

¶¶Difference in number of sustained abstinent participants between the treatment programmes according to 5–8 years of follow-up.

na, not applicable.